Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 29, Number 9—September 2023

Research

Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020–2021

Katherine NewellComments to Author , Marc Fischer, Stephanie Massey, Laurie Orell, Jonathan Steinberg, Megan Tompkins, Louisa Castrodale, and Joseph McLaughlin
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Newell, M. Fisher, L. Orell, J. Steinberg); Alaska Division of Public Health, Anchorage, Alaska, USA (K. Newell, S. Massey, M. Tompkins, L. Castrodale, J. McLaughlin)

Main Article

Table 1

Timing of SARS-CoV-2 detection in patients who had IPD and temporally associated SARS-CoV-2 infection, Alaska, USA, 2020–2021*

Timing of SARS-CoV-2 detection†
 Nonfatal cases, no. (%), n = 46
 Fatal cases, no. (%), n = 9
1‒30 d before IPD 21 (46) 6 (66)
Same day as IPD 19 (41) 3 (33)
1‒30 d after IPD 6 (13) 0

*IPD, invasive pneumococcal disease. †Difference between dates of specimen collection.

Main Article

Page created: July 20, 2023
Page updated: August 20, 2023
Page reviewed: August 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external